ScreenerHero

EVGNEvogene Ltd.

NAS · US · Healthcare · Biotechnology · evogene.com
0.5625USDMkt Cap: 8.89M $P/E: —

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Ap…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap8.89M $
Enterprise Value5.37M $
Revenue (TTM)1.84M $
Gross Profit-241.00K $
Net Income (TTM)-8.48M $
Revenue/Share0.2140 USD
Last Price0.5625 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees52
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.70
PEG—
EV/EBITDA-0.40
EV/Revenue2.91
P/S4.82
P/B-2.31
EPS (TTM)-1.75
EPS (Forward)-0.80
52W Range
0.541255% of range0.5800
52W High0.5800 USD
52W Low0.5412 USD
Profitability
Gross Margin-6.25%
Oper. Margin-952.10%
EBITDA Margin0.00%
Profit Margin-220.22%
ROE10347.56%
ROA-42.33%
Growth
Revenue Growth-86.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.50M $
CapEx (TTM)135.00K $
FCF Margin-661.86%
FCF Yield-137.31%
Net Debt-11.02M $
Net Debt/EBITDA0.83
Balance Sheet
Debt/Equity-26.80
Current Ratio2.79
Quick Ratio2.75
Book Value/Sh-0.2430 USD
Cash/Share1.254 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 25, 2024
Analyst Consensus
Rating—
Target (Mean)2.150 USD
Upside (mean)+282.2%
Target Range2.150 USD – 2.150 USD
# Analysts1
Ownership
Shares Out.15.80M
Float8.51M
Insiders27.85%
Institutions6.36%
Short Interest
Short Ratio0.0d
Short % Float0.29%
Short % Out.0.29%
Shares Short45.13K
Short (prev mo.)207.37K
Technical
SMA 500.5336 (+5.4%)
SMA 2000.8247 (-31.8%)
Beta0.68
S&P 52W Chg19.18%
Avg Vol (30d)1.01M
Avg Vol (10d)1.09M
Technical Indicators
RSI (14)48.6
MACD0.0112
MACD Signal0.0186
MACD Hist.-0.0074
BB Upper0.7167 USD
BB Middle0.5806 USD
BB Lower0.4445 USD
BB Width46.88%
ATR (14)0.0739 USD
Vol Ratio (20d)1.66x